Status:
COMPLETED
Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Collaborating Sponsors:
Spanish Network for Research in Infectious Diseases
Grupo de Estudio de la Infección en el Trasplante (GESITRA)
Conditions:
Transplant Recipient
Infections, Coronavirus
Eligibility:
All Genders
16+ years
Brief Summary
The overall purpose of this project is to better understand the incidence, risk factors, etiology, clinical manifestations and outcome of tCOVID19 in solid organ transplant recipients. The results obt...
Detailed Description
There will be a clinical follow-up of the patients included in this study to observe possible complications and survival rate. Data collected form this study will be evaluated with a descriptive stati...
Eligibility Criteria
Inclusion
- Patients older than 16 years with a solid organ transplant diagnosed of COVID-19.
- NOTE: A confirmed case of infection, is defined by a clinical syndrome that is compatible to that of an respiratory infection (fever, cough and/or dyspnea) and the presence of a positive microbiological result.
Exclusion
- Absence of informed consent after giving the information regarding the study.
Key Trial Info
Start Date :
March 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
488 Patients enrolled
Trial Details
Trial ID
NCT04319172
Start Date
March 12 2020
End Date
December 31 2023
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Virgen del Rocio
Seville, Spain, 41013